ALHC
Alignment Healthcare LLC
8.40$
-1.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -23.2% | +7.0% | +13.1% | -3.3% | +13.0% | +14.5% | +11.7% | +10.2% | -3.3% | +18.4% | +1.4% | |
| – | -27.5% | +7.7% | +15.1% | -4.3% | +15.3% | +17.1% | +13.6% | +12.0% | -3.4% | +20.4% | +1.3% | |
| – | -48.2% | +17.7% | +41.9% | +0.4% | +27.2% | +3.1% | +5.4% | +31.4% | -6.8% | +22.5% | -1.7% | |
| – | -38.2% | -5.4% | +20.5% | +4.7% | +23.5% | +1.9% | +5.1% | +27.9% | -6.2% | +20.2% | -3.4% | |
| – | +13.5% | +37.8% | +11.0% | -24.2% | +10.8% | +39.1% | +32.2% | -22.3% | +15.2% | +9.7% | +6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -1.8% | -6.2% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -0.5% | -0.5% | -0.4% | -12.5% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -25.4% | +15.5% | +18.0% | -2.5% | +18.1% | +15.5% | +9.2% | +9.5% | -5.8% | +19.0% | -3.9% | |
| – | -35.9% | +25.7% | +12.3% | -3.6% | -1.7% | +29.9% | +15.8% | +15.4% | -8.9% | +30.1% | -5.7% | |
| – | -93.2% | – | – | – | -24.9% | – | – | – | – | – | – | |
| – | +570.7% | +31.6% | +11.2% | -9.3% | +7.4% | +27.3% | +17.0% | +12.6% | +2.2% | +18.9% | -16.3% | |
| – | +0.1% | +0.1% | +30.7% | -0.6% | +52.8% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | |
| – | -16.7% | -16.6% | -5.5% | -7.4% | -12.8% | +8.3% | +30.4% | +14.8% | +10.8% | +15.4% | +28.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | +0.4% | +1.0% | +0.2% | +0.3% | +0.9% | +8.2% | -0.3% | -3.8% | +6.0% | +0.9% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.